Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Bioinformatics

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 451-475 out of 964.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>

Public Release: 11-Jul-2016
Biodiversity Data Journal
More assassins on the radar: As many as 24 new species of assassin bugs described
As many as 24 assassin bugs new to science were discovered by Dr. Guanyang Zhang and his team. In their article, published in the open access Biodiversity Data Journal, they describe the new insects along with treating another 47 assassin bugs in the same genus. To do this, the scientists examined more than 10,000 specimens, coming from both museum collections and newly undertaken field trips.

Contact: Dr Guanyang Zhang
gyz151@gmail.com
Pensoft Publishers

Public Release: 11-Jul-2016
Nature Communications
Open chromatin profiling key to identifying leukemia cells of origin
Researchers have found a precise and reliable way -- whole-genome profiling of open chromatin -- to identify the kind of cell that leads to a given case of leukemia, a valuable key to cancer prognosis and outcome.
NIH/National Cancer Institute

Contact: Joyce Peterson
joyce.peterson@jax.org
207-288-6058
Jackson Laboratory

Public Release: 8-Jul-2016
Nature Biotechnology
Web-based data tool designed to enhance drug safety
A new online open-access database has been developed by scientists to allow the clinical responses of more than 5 million patients to all FDA-approved drugs to be used to identify unexpected clinical harm, benefits and alternative treatment choices for individual patients.
National Institutes of Health

Contact: Jim Feuer
jim.feuer@cchmc.org
513-636-4656
Cincinnati Children's Hospital Medical Center

Public Release: 7-Jul-2016
Research aims to grasp complexities in plant-pollinator networks across tallgrass prairies
University of Kansas graduate student Kathy Denning has earned a grant from the National Science Foundation to support research centering on molecular genetic analysis of pollen grains recovered from bees across 10 prairie sites in Kansas.
National Science Foundation

Contact: Brendan M. Lynch
brendan@ku.edu
785-864-8855
University of Kansas

Public Release: 7-Jul-2016
Vanderbilt chosen for leadership role in NIH precision medicine initiative cohort program
Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced.
National Institutes of Health

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 7-Jul-2016
Joint forces to enhance access to biodiversity monitoring data
Combining forces, two EU projects, EuMon and EU BON, are set to compile the largest data collection on biodiversity monitoring activities in Europe to date. Using existing biodiversity data and metadata collected by the two projects, the initiative is a stepping stone in completing a comprehensive European Biodiversity Portal. The projects now call out to monitoring programs across the Old Continent and beyond, to join in, provide information about their schemes and share their expertise.

Contact: Dr. Klaus Henle
klaus.henle@ufz.de
Pensoft Publishers

Public Release: 7-Jul-2016
JCI Insight
Various miRNAs predict the effect of anti-angiogenic agents on renal cancer
CNIO researchers have come across various potential predictive biomarkers of tyrosine kinase inhibitors (TKI) -- a type of anti-angiogenic agent widely used -- response in metastatic renal cancer. In their study, published in JCI Insight, the researchers identify various miRNAs that define a group of patients with the poorest response to TKI treatment and with the worst prognosis. The study, conducted on 139 patient samples, is the most robust to date in renal cell carcinoma.
Mutua Madrileña Foundation, Pfizer, Fund for Health Research Project, Spanish Ministry of Economy, Competitiveness

Contact: Nuria Noriega
comunicacion@cnio.es
34-917-328-000
Centro Nacional de Investigaciones Oncológicas (CNIO)

Public Release: 7-Jul-2016
Cell
Cancer cell lines predict drug response
A discovery that cancer cell lines can be used to predict how a tumor is likely to respond to a drug has implications for developing new, personalized treatments.
Wellcome Trust, European Molecular Biology Laboratory, NIH/National Cancer Institute, Netherlands Organization for Scientific Research, EU/Seventh Framework Programme, La Fundació la Marató de TV3, European Research Council

Contact: Mary Todd Bergman
mary@ebi.ac.uk
44-788-137-7941
European Molecular Biology Laboratory - European Bioinformatics Institute

Public Release: 6-Jul-2016
Genetics
'Omics' data improves breast cancer survival prediction
Precise predictions of whether a tumor is likely to spread would help clinicians and patients choose the best course of treatment. But current methods fall short of the precision needed. New research reveals that profiling primary tumor samples using genomic technologies can improve the accuracy of breast cancer survival predictions compared to clinical information alone. The study was published in the journal GENETICS, a publication of the Genetics Society of America.
National Institutes of Health, National Science Foundation, American Cancer Society, University of Alabama at Birmingham-Comprehensive Cancer Center

Contact: Cristy Gelling
cgelling@thegsajournals.org
412-478-3537
Genetics Society of America

Public Release: 6-Jul-2016
Research Ideas & Outcomes
Biodiversity data import from historical literature assessed in an EMODnet Workshop Report
Information on species occurrences through the centuries is crucial for adopting timely measures against biodiversity loss. However, as abundant as information currently is, much of the actual data are effectively inaccessible. Therefore, data managers, who implement data archaeology and rescue activities, along with external experts in data mobilization and publication, were brought together for the European Marine Observation and Data network Workshop. The event is reported in the open access journal Research Ideas and Outcomes.

Contact: Sarah Faulwetter
sarifa@hcmr.gr
Pensoft Publishers

Public Release: 6-Jul-2016
Nature
Anatomy of a decision
A new atlas of gene expression during the earliest stages of life boosts studies of development.
Wellcome Trust, European Molecular Biology Laboratory, Biotechnology and Biological Sciences Research Council, Medical Research Council

Contact: Mary Todd Bergman
mary@ebi.ac.uk
44-788-137-7941
European Molecular Biology Laboratory - European Bioinformatics Institute

Public Release: 5-Jul-2016
Integrative and Comparative Biology
Researchers tally huge number of venomous fishes, tout potential for medical therapies
A paper appearing this week in the journal Integrative and Comparative Biology catalogs instances of venomous aquatic life, for the first time showing that venom has evolved 18 separate times in fresh and saltwater fishes.

Contact: Brendan M. Lynch
brendan@ku.edu
785-864-8855
University of Kansas

Public Release: 5-Jul-2016
Nature Nanotechnology
From super to ultra-resolution microscopy
A team at Harvard's Wyss Institute for Biologically Inspired Engineering has, for the first time, been able to tell apart features distanced only 5 nanometers from each other in a densely packed, single molecular structure and to achieve the so far highest resolution in optical microscopy. Reported on July 4 in a study in Nature Nanotechnology, the technology, also called 'discrete molecular imaging', enhances the team's DNA nanotechnology-powered super-resolution microscopy platform with an integrated set of new imaging methods.

Contact: Benjamin Boettner
Benjamin.Boettner@wyss.harvard.edu
917-913-8051
Wyss Institute for Biologically Inspired Engineering at Harvard

Public Release: 3-Jul-2016
BMC Genomics
Unraveling the genes for sexual traits in stag beetles
Scientists have built a gene expression database of a stag beetle and identified genes important for sex determination and differentiation.

Contact: Naoki NAMBA (Media Officer)
pr@oia.hokudai.ac.jp
81-117-068-034
Hokkaido University

Public Release: 1-Jul-2016
GigaScience
Decoding the complete genome of the Mediterranean's most emblematic tree: The olive
A team of scientists from three Spanish centers has sequenced, for the first time ever, the complete genome of the olive tree. The results have been just published today in the Open Access journal GigaScience. This work will facilitate genetic improvement for production of olives and olive oil, two key products in the Spanish economy and diet. The specimen sequenced is an olive tree of the Farga variety, one of the most widespread in eastern Spain, and over 1,300 years old.
Fundación Banco Santander

Contact: Laia Cendros
laia.cendros@crg.eu
34-607-611-798
Center for Genomic Regulation

Public Release: 1-Jul-2016
Scientific Reports
The discovery of a totally new kind of 'mark' in human cell nucleus
A Japanese research group verified the presence of a protein modification that is a unique mark in human cell nucleus. This protein modification, Histone H4 lysine 20 acetylation (H4K20ac), was only discovered in plant cells and its existence in mammalian cells has been indirectly proven. Their study suggests that H4K20ac is associated with gene repression. This new discovery of H4K20ac may lead to further clarification of the mechanisms in disease progression.

Contact: Saori Obayashi
saori_obayashi@mail.osaka-u.ac.jp
81-661-055-886
Osaka University

Public Release: 30-Jun-2016
Scientific Reports
New technology helps ID aggressive early breast cancer
Researchers at the University of Michigan developed a new technology that can identify aggressive forms of ductal carcinoma in situ, or stage 0 breast cancer, from non-aggressive varieties.
Mildred E. Swanson Foundation, National Institutes of Health

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
Michigan Medicine - University of Michigan

Public Release: 30-Jun-2016
Cell Metabolism
Natural metabolite can suppress inflammation
An international research team has revealed a substance produced in humans that can suppress the pro-inflammatory activity of macrophages -- specific immune cells. The substance known as itaconate is released in large quantities by macrophages themselves and according to the scientists, acts as an antioxidant and anti-inflammatory agent. These properties make itaconate promising for the treatment of such pathologies as cardiac ischemia, metabolic disorders and autoimmune diseases which may be associated with excessive inflammation or oxidative stress.
National Institutes of Health, DFG, University of California Davis, CSD Consortium, UC Davis and CHORI/KOMP Repository, Canadian Institutes for Health Research, US Department of Veterans Affairs

Contact: Dmitry Malkov
dvmalkov@corp.ifmo.ru
7-953-377-5508
ITMO University

Public Release: 30-Jun-2016
Grant to The Jackson Laboratory for Gene Expression Database
The Jackson Laboratory's Gene Expression Database (GXD), an open resource for the international biomedical research community, will receive a total of $10.5 million in support over the next five years from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.
NIH/Eunice Kennedy Shriver National Institute of Child Health & Human Development

Contact: Joyce Peterson
joyce.peterson@jax.org
207-288-6058
Jackson Laboratory

Public Release: 30-Jun-2016
Scientific Reports
Bioinformatics software is developed to predict the effect of cancer-associated mutations
Biology and computing have joined forces to create a piece of software that analyses mutations in proteins; these mutations are potential inducers of diseases, such as cancer. The geneticists Asier Fullaondo and José Antonio Rodríguez, and the telecommunications engineer Gorka Prieto have created WREGEX 2.0, a free, easy, versatile and, above all, fast bioinformatics application that is capable of analyzing and combining the information from 40,000 proteins within the space of one minute.

Contact: Matxalen Sotillo
komunikazioa@ehu.eus
34-688-673-770
University of the Basque Country

Public Release: 30-Jun-2016
Science
Scientists discover maleness gene in malaria mosquitoes
Scientists, led by Dr. Jaroslaw Krzywinski, Head of the Vector Molecular Biology group at The Pirbright Institute have isolated a gene, which determines maleness in the species of mosquito that is responsible for transmitting malaria. The research, published in the journal Science, describes identification and characterization of a gene, named Yob by the authors, which is the master regulator of the sex determination process in the African malaria mosquito, Anopheles gambiae, and determines the male sex.
Liverpool School of Tropical Medicine, Wellcome Trust, The Pirbright Institute, Biotechnology and Biological Sciences Research Council

Contact: Teresa Maughan
communications@pirbright.ac.uk
44-148-323-1120
The Pirbright Institute

Public Release: 29-Jun-2016
Significant expansion of data available in the Genomic Data Commons
Recently launched Genomic Data Commons will get a dramatic increase in the power and utility of its resources with the announcement today of the signing of a data sharing agreement between the National Cancer Institute and Foundation Medicine Inc., a molecular information company that has generated genomic profiles of people with cancer.

Contact: NCI Press Officers
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute

Public Release: 28-Jun-2016
Nature Communications
Researchers find protein signatures for accurate noninvasive diagnosis of prostate cancer
Researchers at the Ontario Institute for Cancer Research and University Health Network in Toronto, along with researchers at the Eastern Virginia Medical School, have created protein signatures that accurately diagnose prostate cancer and can distinguish between patients with aggressive versus non-aggressive disease using a simple urine sample.

Contact: Christopher Needles
christopher.needles@oicr.on.ca
416-673-8505
Ontario Institute for Cancer Research

Public Release: 28-Jun-2016
Nature Methods
Unidentified spectra detector
- New algorithm clusters hundreds of millions of unidentified peptide sequences for analysis; By clustering all public mass spectrometry spectra in the PRIDE Archive proteomics resource, researchers detected incorrectly identified, low-quality and unidentified spectra. A new tool, PRIDE Cluster, simplifies further investigation into unidentified spectra.
European Molecular Biology Laboratory

Contact: Mary Todd Bergman
mary@ebi.ac.uk
44-788-137-7941
European Molecular Biology Laboratory - European Bioinformatics Institute

Public Release: 27-Jun-2016
Molecular Biology of the Cell
IU study: Virtual tissue technology reveals new drug target in polycystic kidney disease
Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States. The study, which reveals that errors in how cells stick together give rise to two forms of kidney cysts, appears in the journal Molecular Biology of the Cell.
National Institutes of Health

Contact: Kevin Fryling
kfryling@iu.edu
812-856-2988
Indiana University

Showing releases 451-475 out of 964.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>